
Sign up to save your podcasts
Or


FDA commissioners come and go, but career civil servants are always there, applying the rules without financial conflicts of interest.
Dr. Robert Califf served as FDA Commissioner twice, making him one of the most experienced regulatory leaders in healthcare history. Before FDA, he built the world's largest clinical research institute at Duke and spent time in Silicon Valley with Google's Verily. Now he writes weekly on Substack, sharing opinions on controversial topics with specific evidence and nuance.
In this episode, Shannon Lantzy talks with Dr. Califf about the referee role of the FDA, why political appointees shouldn't make decisions about individual products, and what delighted him most during his terms. They discuss the history of why we regulate medical products differently than consumer goods, how AI could transform regulatory review, and why studying failures teaches more than studying successes.
Timestamps:
00:00 – Regulators as referees who apply rules made by politicians
02:00 – Why the man in the arena is also the referee
04:00 – How honest referees keep societies and sports functioning
06:00 – Commissioner vs. center directors: political vs. career civil servants
08:00 – When rules reflect cultural beliefs vs. scientific evidence
11:00 – Why middle schoolers need to understand FDA's mission
13:00 – Health is different from consumer products: we don't experiment on expendable humans
15:00 – Regulatory innovation before the boom: unsung but vital
17:00 – The hardest thing: keeping hands off individual product decisions
19:00 – Everything delightful: teams working together under imperfect information
21:00 – When ICDs showed 40% reduction in sudden death
23:00 – AI for automated detection and its impact on clinical decisions
26:00 – Why we need regulatory systems to channel activity toward benefit
27:00 – Evidence-based decision making and controversial approvals
30:00 – The iceberg: most FDA impact happens in decisions you never see
32:00 – Moving toward public knowledge of early studies and failures
34:00 – How AI can summarize decisions in minutes for good or harm
35:00 – Rapid fire: Keep your compass on being a good referee
Follow Shannon and Robert:
Connect with Shannon:
LinkedIn: https://www.linkedin.com/in/shannonlantzy
Website: https://www.shannonlantzy.com
Connect with Robert:
Substack: https://robcaliff272993.substack.com/
LinkedIn: https://www.linkedin.com/in/robert-califf-69040016/
By Shannon LantzyFDA commissioners come and go, but career civil servants are always there, applying the rules without financial conflicts of interest.
Dr. Robert Califf served as FDA Commissioner twice, making him one of the most experienced regulatory leaders in healthcare history. Before FDA, he built the world's largest clinical research institute at Duke and spent time in Silicon Valley with Google's Verily. Now he writes weekly on Substack, sharing opinions on controversial topics with specific evidence and nuance.
In this episode, Shannon Lantzy talks with Dr. Califf about the referee role of the FDA, why political appointees shouldn't make decisions about individual products, and what delighted him most during his terms. They discuss the history of why we regulate medical products differently than consumer goods, how AI could transform regulatory review, and why studying failures teaches more than studying successes.
Timestamps:
00:00 – Regulators as referees who apply rules made by politicians
02:00 – Why the man in the arena is also the referee
04:00 – How honest referees keep societies and sports functioning
06:00 – Commissioner vs. center directors: political vs. career civil servants
08:00 – When rules reflect cultural beliefs vs. scientific evidence
11:00 – Why middle schoolers need to understand FDA's mission
13:00 – Health is different from consumer products: we don't experiment on expendable humans
15:00 – Regulatory innovation before the boom: unsung but vital
17:00 – The hardest thing: keeping hands off individual product decisions
19:00 – Everything delightful: teams working together under imperfect information
21:00 – When ICDs showed 40% reduction in sudden death
23:00 – AI for automated detection and its impact on clinical decisions
26:00 – Why we need regulatory systems to channel activity toward benefit
27:00 – Evidence-based decision making and controversial approvals
30:00 – The iceberg: most FDA impact happens in decisions you never see
32:00 – Moving toward public knowledge of early studies and failures
34:00 – How AI can summarize decisions in minutes for good or harm
35:00 – Rapid fire: Keep your compass on being a good referee
Follow Shannon and Robert:
Connect with Shannon:
LinkedIn: https://www.linkedin.com/in/shannonlantzy
Website: https://www.shannonlantzy.com
Connect with Robert:
Substack: https://robcaliff272993.substack.com/
LinkedIn: https://www.linkedin.com/in/robert-califf-69040016/